1. Academic Validation
  2. Identification of DNMT1 selective antagonists using a novel scintillation proximity assay

Identification of DNMT1 selective antagonists using a novel scintillation proximity assay

  • J Biol Chem. 2013 Jul 5;288(27):19673-84. doi: 10.1074/jbc.M112.443895.
Jessica A Kilgore 1 Xinlin Du Lisa Melito Shuguang Wei Changguang Wang Hang Gyeong Chin Bruce Posner Sriharsa Pradhan Joseph M Ready Noelle S Williams
Affiliations

Affiliation

  • 1 Department of Biochemistry, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390, USA.
Abstract

A novel scintillation proximity high throughput assay (SPA) to identify inhibitors of DNA methyltransferases was developed and used to screen over 180,000 compounds. The majority of the validated hits shared a quinone core and several were found to generate the Reactive Oxygen Species, H2O2. Inhibition of the production of H2O2 by the addition of catalase blocked the ability of this group of compounds to inhibit DNA Methyltransferase (DNMT) activity. However, a related compound, SW155246, was identified that existed in an already reduced form of the quinone. This compound did not generate H2O2, and catalase did not block its ability to inhibit DNA Methyltransferase. SW155246 showed a 30-fold preference for inhibition of human DNMT1 versus human or murine DNMT3A or -3B, inhibited global methylation in HeLa cells, and reactivated expression of the tumor suppressor gene RASSF1A in A549 cells. To our knowledge, this work represents the first description of selective chemical inhibitors of the DNMT1 Enzyme.

Keywords

DNA Methylation; DNA Methyltransferase; Gene Regulation; High Throughput Screening (HTS); Reactive Oxygen Species (ROS); Scintillation Proximity Assay.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》